The expressions of p16 and p21 to predict the clinicopathological behavior and prognosis of gastric cancer

E Altun, M Calık, E Demırcı… - Journal of Experimental …, 2015 - dergipark.org.tr
… small cell lung cancers: An immunohistochemical study. Int. J… Expression of p16 gene and
Rb protein in gastric carcinomap21 and p53 expression in gastric cancer. The Korean J. İnt. …

… -derived growth factor (PDGF)-B and vascular endothelial growth factor-A expression, PDGF receptor-β phosphorylation, and microvessel density in gastric cancer

S Suzuki, Y Dobashi, Y Hatakeyama, R Tajiri… - BMC cancer, 2010 - Springer
expression pattern of PDGF-B and VEGF-A in tumor cells and activation of PDGFR-β tyrosine
kinases in stromal cells of human gastric adenocarcinoma; … Immunohistochemical analyses

STAT3 signaling drives EZH2 transcriptional activation and mediates poor prognosis in gastric cancer

YM Pan, CG Wang, M Zhu, R Xing, JT Cui, WM Li… - Molecular cancer, 2016 - Springer
… Furthermore, the association of STAT3 and EZH2 immunohistochemical expression
levels with clinicopathological features was evaluated in 63 GC samples (Table 2). STAT3 …

The opposite prognostic significance of nuclear and cytoplasmic p21 expression in resectable gastric cancer patients

Y Huang, W Wang, Y Chen, Y Huang, J Zhang… - Journal of …, 2014 - Springer
… (TMA) to evaluate the subcellular p21 expression by immunohistochemistry (IHC) in three
… described in our previous study [27]. Expression of nuclear and cytoplasmic p21 in tumor vs. …

[引用][C] Gastric Cancer Literature

MH Smith - Int J Cancer - cancerbio.net
… between VEGF gene polymorphisms and gastric cancer (GC) … p73 G4C14-toA4T14 and p53
gene polymorphisms and their … Observation of an immunohistochemical analysis of various …

Rb family proteins in gastric cancer

L Cito, F Pentimalli, I Forte, E Mattioli… - Oncology …, 2010 - spandidos-publications.com
… Consistent with this result, immunohistochemistry performed … pRb2/p130 deregulation may
be involved in gastric cancer, … pylori infection generated gastric cancer through p53-Rb tumor-…

SUZ12 promotes gastric cancer cell proliferation and metastasis by regulating KLF2 and E-cadherin

R Xia, F Jin, K Lu, L Wan, M Xie, T Xu, W De, Z Wang - Tumor Biology, 2015 - Springer
… As another subunit of PRC2, EZH2 was demonstrated to be involved in … human gastric
cancer [15, 16]. However, the SUZ12 expression pattern and biological function in gastric cancer

[HTML][HTML] Clinicopathological significance of E-cadherin, β-catenin and p53 expression in gastric adenocarinoma

MR Zali, O Moaven, HA Aghdaee… - Journal of Research …, 2009 - ncbi.nlm.nih.gov
study, we evaluated the immunohistochemical expression of … Abnormal expression patterns
of β- catenin were also more … has been reported for p53 expression in gastric cancer and its …

Enhancer of zeste homologue 2 expression in breast carcinoma smears in relationship with p53, Ki-67 and other prognostic parameters

AM Athanassiadou, A Tsipis, E Patsouris, M Gonidi… - Acta cytologica, 2011 - karger.com
Immunohistochemistry detected HER-2 positivity in 42% of the patients. Table 2 shows EZH
2, Ki-67 and p53 staining patterns … A: EZH2 is a marker of aggressive breast cancer and …

[HTML][HTML] A clinical–biological risk stratification model for resected gastric cancer: prognostic impact of Her2, Fhit, and APC expression status

E Bria, G De Manzoni, S Beghelli, A Tomezzoli… - Annals of oncology, 2013 - Elsevier
analysis, p53 status resulted to be an independent prognostic marker [2, 14, 15]. … the
immunohistochemical expression of seven proteins: Cdx2, APC, β-catenin, E-cadherin, Fhit, p53, …